We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.59%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$10.3B
AUM Growth
+$817M
(+8.7%)
Cap. Flow
+$647M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
9.34%
Holding
2,856
New
754
Increased
869
Reduced
698
Closed
531
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$97.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$93.9M |
| 3 |
VF Corp
VFC
|
+$71.9M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$69.6M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$113M |
| 2 |
TJX Companies
TJX
|
+$95.9M |
| 3 |
Yum! Brands
YUM
|
+$87.7M |
| 4 |
Colgate-Palmolive
CL
|
+$69.2M |
| 5 |
Walt Disney
DIS
|
+$68.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.03% |
| 2 | Technology | 12.14% |
| 3 | Financials | 10.96% |
| 4 | Healthcare | 10.46% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
DNA X Inc
SONM
$4.69M
| $353K | ﹤0.01% |
+15
| New | +$381K |
|
1852
BioXcel Therapeutics
BTAI
$26.2M
| $352K | ﹤0.01% |
+2,010
| New | +$340K |
|
|
AKS
1853
DELISTED
AK Steel Holding Corp
AKS
| $352K | ﹤0.01% |
+148,713
| New | +$346K |
|
|
ACHN
1854
DELISTED
Achillion Pharmaceuticals
ACHN
| $352K | ﹤0.01% |
131,168
+89,761
| +217% | +$265K |
|
1855
Interparfums
IPAR
$3.92B
| $351K | ﹤0.01% |
5,273
-18,808
| -78% | -$1.31M |
|
1856
Arcosa
ACA
$7.12B
| $350K | ﹤0.01% |
9,311
-101,498
| -92% | -$3.47M |
|
1857
OptimizeRx
OPRX
$117M
| $350K | ﹤0.01% |
+21,600
| New | +$292K |
|
1858
Liberty Global Class C
LBTYK
$3.27B
| $349K | ﹤0.01% |
+13,153
| New | +$338K |
|
1859
LeMaitre Vascular
LMAT
$2.18B
| $349K | ﹤0.01% |
+12,465
| New | +$346K |
|
1860
Park-Ohio Holdings
PKOH
$554M
| $348K | ﹤0.01% |
10,676
+2,920
| +38% | +$99.3K |
|
1861
CarGurus
CARG
$3.01B
| $347K | ﹤0.01% |
9,600
-118,584
| -93% | -$4.45M |
|
1862
Invitation Homes
INVH
$17.7B
| $347K | ﹤0.01% |
12,995
-76,076
| -85% | -$1.94M |
|
1863
Center Bancorp
CNOB
$1.63B
| $346K | ﹤0.01% |
15,290
-6,447
| -30% | -$139K |
|
1864
Lexicon Pharmaceuticals
LXRX
$1.02B
| $346K | ﹤0.01% |
54,999
-19,654
| -26% | -$118K |
|
|
OLP
1865
One Liberty Properties
OLP
$548M
| $346K | ﹤0.01% |
+11,933
| New | +$345K |
|
1866
Watsco Inc
WSO
$14.9B
| $346K | ﹤0.01% |
2,115
-58,717
| -97% | -$9.22M |
|
|
YELL
1867
DELISTED
Yellow Corporation Common Stock
YELL
| $346K | ﹤0.01% |
85,900
+74
| +0.1% | +$428 |
|
1868
Columbia Sportswear
COLM
$3.19B
| $345K | ﹤0.01% |
3,449
-79,265
| -96% | -$7.86M |
|
1869
Costamare
CMRE
$1.9B
| $344K | ﹤0.01% |
67,136
+56,739
| +546% | +$311K |
|
1870
TTM Technologies
TTMI
$13.6B
| $344K | ﹤0.01% |
33,683
-57,240
| -63% | -$634K |
|
|
PRNB
1871
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $343K | ﹤0.01% |
+10,329
| New | +$322K |
|
1872
Avanos Medical
AVNS
$1.17B
| $341K | ﹤0.01% |
+7,821
| New | +$335K |
|
1873
AstroNova
ALOT
$223M
| $340K | ﹤0.01% |
+13,162
| New | +$334K |
|
1874
Bilibili
BILI
$7.18B
| $340K | ﹤0.01% |
+20,923
| New | +$338K |
|
1875
EXL Service
EXLS
$4.23B
| $339K | ﹤0.01% |
25,595
-15,025
| -37% | -$184K |
|
Similar funds
Squarepoint's Q2 2019 Portfolio in Review
As of Q2 2019, Squarepoint held 2,856 positions worth $10.3B, up 8.7% from $9.44B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Squarepoint deployed $647M of net new capital in Q2 2019, opening 754 new positions and adding to 869 existing holdings. Its largest new stake was Celgene Corp: 988,338 shares worth $91.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dollar General, an estimated $113M trimmed.
- Squarepoint's largest Q2 2019 buy was Celgene Corp: 988,338 shares worth $91.4M.
- Squarepoint added most to Amazon in Q2 2019, an estimated $97.9M increase.
- Squarepoint's biggest Q2 2019 reduction was Dollar General, cutting an estimated $113M.
- Squarepoint fully exited iShares MSCI India ETF in Q2 2019, selling an estimated $55.7M.
- Squarepoint's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2019.
- Squarepoint opened 754 new positions and closed 531 in Q2 2019.
- Squarepoint's portfolio value rose 8.7% quarter-over-quarter to $10.3B.
Based on Squarepoint's 13F filing for Q2 2019, filed 14 Aug 2019.